Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Sanofi and Seagen collaborate to develop novel antibody-drug conjugates

March 16, 2022 Research and Development

Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …
News
national-cancer-institute-uurfmwa25f0-unsplash

NICE guidance for treating relapsed and refractory multiple myeloma

March 16, 2022 Research and Development

NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …
News

FDA approves Symbicort to treat asthma and COPD

March 16, 2022 Research and Development

The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …
News

FDA clearance for clinical surveillance solution

March 16, 2022 Research and Development

The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
News

Vicore adds to rare lung disease pipeline with PAH indication

March 9, 2022 Research and Development

Vicore Pharma has announced plans to initiate a clinical trial with C21 in pulmonary arterial hypertension (PAH).
News

NICE draft guidance does not recommend pembrolizumab plus chemo for triple negative breast cancer

March 9, 2022 Research and Development

Draft guidance published by NICE for public consultation does not recommend pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) for …
News

Omicron sub-variant BA.2 makes up 11.6% of COVID-19 variants in US

March 9, 2022 Research and Development

The CDC said that the BA.2 sub-variant of Omicron is estimated to be 11.6% of the coronavirus variants circulating in …
News

MHRA authorisation of new treatment for chronic kidney disease associated with diabetes

March 9, 2022 Research and Development

The MHRA has authorised the use of Kerendia® (finerenone) (10mg or 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) …
News

First smart connected insulin pens made available on NHS

March 2, 2022 Research and Development

Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
News

Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment

March 2, 2022 Research and Development

The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
News

HPV vaccines could mean only one smear test a lifetime

March 2, 2022 Research and Development

A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
News

FDA share new trial guidelines to further cancer therapy development

March 2, 2022 Research and Development

The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022 Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
News

Extra blood test could help detect risk of death from heart attack

February 23, 2022 Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
News

FDA places gene therapy trial on hold

February 23, 2022 Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026